UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

16 Jul 2007

UCB APPOINTS DETLEF THIELGEN AS CHIEF FINANCIAL OFFICER

Read More
13 Jul 2007

UCB Announces Registration of Domination and Profit Transfer Agreement Allowing Full Integration of Schwarz Pharma

Read More
2 Jul 2007

Luc Missorten has decided to pursue new opportunities

Read More
26 Jun 2007

UCB and Biogen Idec's oral VLA-4 antagonist (CDP323) enters phase II development for Multiple Sclerosis

Read More
14 Jun 2007

CIMZIA(TM) Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis

Read More
29 May 2007

FDA approves XYZAL(R) tablets for the treatment of seasonal and year round allergies, and chronic urticaria

Read More

Stay up-to-date on the latest news and information from UCB